DE69814118T2 - Anti-first-pass-effect-substanzen - Google Patents
Anti-first-pass-effect-substanzen Download PDFInfo
- Publication number
- DE69814118T2 DE69814118T2 DE69814118T DE69814118T DE69814118T2 DE 69814118 T2 DE69814118 T2 DE 69814118T2 DE 69814118 T DE69814118 T DE 69814118T DE 69814118 T DE69814118 T DE 69814118T DE 69814118 T2 DE69814118 T2 DE 69814118T2
- Authority
- DE
- Germany
- Prior art keywords
- compound
- optionally substituted
- formula
- group
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 0 *C1(*)OCOC1*=C Chemical compound *C1(*)OCOC1*=C 0.000 description 3
- CRBBFCKVJXGEEA-OAMFTAOGSA-N CC(C(CC/C(/C)=C/COc1c(C=CC(O2)=O)c2cc2c1cc[o]2)O1)OC11Oc(cc(cc2)OC/C=C(\C)/CCOC(C)(C)C)c2C=C1 Chemical compound CC(C(CC/C(/C)=C/COc1c(C=CC(O2)=O)c2cc2c1cc[o]2)O1)OC11Oc(cc(cc2)OC/C=C(\C)/CCOC(C)(C)C)c2C=C1 CRBBFCKVJXGEEA-OAMFTAOGSA-N 0.000 description 1
- YHYWDXQSRDIAFE-ZZZAPRPPSA-N CC1(C)OC1CC/C(/C)=C/COc(cc1)cc2c1C=CC1(OC(C)(C)C(CC/C(/C)=C/COc3c(C=CC(O4)=O)c4cc4c3cc[o]4)O1)O2 Chemical compound CC1(C)OC1CC/C(/C)=C/COc(cc1)cc2c1C=CC1(OC(C)(C)C(CC/C(/C)=C/COc3c(C=CC(O4)=O)c4cc4c3cc[o]4)O1)O2 YHYWDXQSRDIAFE-ZZZAPRPPSA-N 0.000 description 1
- XAKXAFWXIUEQSQ-ZZZAPRPPSA-N CC1(C)OC1CC/C(/C)=C/COc1c(cc[o]2)c2cc2c1C=CC1(OC(C)(C)C(CC/C(/C)=C/COc3ccc(C=CC(O4)=O)c4c3)O1)O2 Chemical compound CC1(C)OC1CC/C(/C)=C/COc1c(cc[o]2)c2cc2c1C=CC1(OC(C)(C)C(CC/C(/C)=C/COc3ccc(C=CC(O4)=O)c4c3)O1)O2 XAKXAFWXIUEQSQ-ZZZAPRPPSA-N 0.000 description 1
- XAKXAFWXIUEQSQ-MHXIOVKLSA-N CC1(C)OC1CC/C(/C)=C/COc1c(cc[o]2)c2cc2c1C=C[C@]1(OC(C)(C)[C@@H](CC/C(/C)=C/COc3ccc(C=CC(O4)=O)c4c3)O1)O2 Chemical compound CC1(C)OC1CC/C(/C)=C/COc1c(cc[o]2)c2cc2c1C=C[C@]1(OC(C)(C)[C@@H](CC/C(/C)=C/COc3ccc(C=CC(O4)=O)c4c3)O1)O2 XAKXAFWXIUEQSQ-MHXIOVKLSA-N 0.000 description 1
- MUGQXQFCWOTOCQ-UHFFFAOYSA-N Cc1c(cc[o]2)c2cc2c1C=CCO2 Chemical compound Cc1c(cc[o]2)c2cc2c1C=CCO2 MUGQXQFCWOTOCQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5638297P | 1997-08-26 | 1997-08-26 | |
| US56382P | 1997-08-26 | ||
| US08/997,259 US6063809A (en) | 1997-08-26 | 1997-12-23 | Anti-first-pass effect compounds |
| US09/001,218 US6124477A (en) | 1996-06-27 | 1997-12-30 | Anti-first-pass effect compounds |
| US1218 | 1997-12-30 | ||
| PCT/US1998/017332 WO1999009976A1 (en) | 1997-08-26 | 1998-08-26 | Anti-first-pass effect compounds |
| US997259 | 2001-11-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69814118D1 DE69814118D1 (en) | 2003-06-05 |
| DE69814118T2 true DE69814118T2 (de) | 2004-04-01 |
Family
ID=27356877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69814118T Expired - Lifetime DE69814118T2 (de) | 1997-08-26 | 1998-08-26 | Anti-first-pass-effect-substanzen |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1019042B1 (https=) |
| JP (1) | JP2001526177A (https=) |
| CN (2) | CN1155377C (https=) |
| AP (1) | AP2000001746A0 (https=) |
| AT (1) | ATE238786T1 (https=) |
| AU (1) | AU750224B2 (https=) |
| BR (1) | BR9812002A (https=) |
| CA (1) | CA2299503C (https=) |
| CZ (1) | CZ295411B6 (https=) |
| DE (1) | DE69814118T2 (https=) |
| DK (1) | DK1019042T3 (https=) |
| ES (1) | ES2199457T3 (https=) |
| IL (1) | IL134408A0 (https=) |
| NZ (1) | NZ502767A (https=) |
| OA (1) | OA11398A (https=) |
| PT (1) | PT1019042E (https=) |
| SI (1) | SI1019042T1 (https=) |
| WO (1) | WO1999009976A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1240831A3 (en) * | 2001-03-15 | 2003-06-04 | Takasago International Corporation | Color fading/discoloration preventive agent |
| US6752862B2 (en) | 2001-03-16 | 2004-06-22 | Takasago International Corporation | Color fading/discoloration preventive agent |
| WO2006136175A2 (en) * | 2005-06-22 | 2006-12-28 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor |
| JP5481746B2 (ja) * | 2009-09-28 | 2014-04-23 | 公益財団法人東洋食品研究所 | フロクマリン類の含有量を低減したイチジクの製造方法 |
| WO2024223797A1 (en) | 2023-04-28 | 2024-10-31 | Institut National de la Santé et de la Recherche Médicale | Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2168696B (en) * | 1984-12-21 | 1989-01-11 | Boehringer Biochemia Srl | Fluoro coumarins as antilymphoedema agents |
-
1998
- 1998-08-26 CA CA002299503A patent/CA2299503C/en not_active Expired - Fee Related
- 1998-08-26 EP EP98942177A patent/EP1019042B1/en not_active Expired - Lifetime
- 1998-08-26 CN CNB988090988A patent/CN1155377C/zh not_active Expired - Fee Related
- 1998-08-26 ES ES98942177T patent/ES2199457T3/es not_active Expired - Lifetime
- 1998-08-26 AP APAP/P/2000/001746A patent/AP2000001746A0/en unknown
- 1998-08-26 JP JP2000507366A patent/JP2001526177A/ja active Pending
- 1998-08-26 AT AT98942177T patent/ATE238786T1/de not_active IP Right Cessation
- 1998-08-26 PT PT98942177T patent/PT1019042E/pt unknown
- 1998-08-26 DK DK98942177T patent/DK1019042T3/da active
- 1998-08-26 BR BR9812002-6A patent/BR9812002A/pt not_active Application Discontinuation
- 1998-08-26 WO PCT/US1998/017332 patent/WO1999009976A1/en not_active Ceased
- 1998-08-26 AU AU90288/98A patent/AU750224B2/en not_active Ceased
- 1998-08-26 SI SI9830480T patent/SI1019042T1/xx unknown
- 1998-08-26 CZ CZ2000695A patent/CZ295411B6/cs not_active IP Right Cessation
- 1998-08-26 IL IL13440898A patent/IL134408A0/xx unknown
- 1998-08-26 CN CNA2004100339712A patent/CN1537856A/zh active Pending
- 1998-08-26 DE DE69814118T patent/DE69814118T2/de not_active Expired - Lifetime
- 1998-08-26 NZ NZ502767A patent/NZ502767A/en unknown
-
2000
- 2000-02-24 OA OA1200000051A patent/OA11398A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA11398A (en) | 2004-04-14 |
| WO1999009976A1 (en) | 1999-03-04 |
| ATE238786T1 (de) | 2003-05-15 |
| JP2001526177A (ja) | 2001-12-18 |
| IL134408A0 (en) | 2001-04-30 |
| AU9028898A (en) | 1999-03-16 |
| EP1019042B1 (en) | 2003-05-02 |
| NZ502767A (en) | 2001-11-30 |
| PT1019042E (pt) | 2003-09-30 |
| CN1155377C (zh) | 2004-06-30 |
| BR9812002A (pt) | 2000-09-26 |
| CN1270519A (zh) | 2000-10-18 |
| CZ295411B6 (cs) | 2005-08-17 |
| SI1019042T1 (en) | 2003-12-31 |
| EP1019042A4 (en) | 2001-07-11 |
| ES2199457T3 (es) | 2004-02-16 |
| CZ2000695A3 (cs) | 2000-08-16 |
| EP1019042A1 (en) | 2000-07-19 |
| CA2299503A1 (en) | 1999-03-04 |
| DK1019042T3 (da) | 2003-08-25 |
| CA2299503C (en) | 2006-08-22 |
| DE69814118D1 (en) | 2003-06-05 |
| CN1537856A (zh) | 2004-10-20 |
| AU750224B2 (en) | 2002-07-11 |
| AP2000001746A0 (en) | 2000-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7514572B2 (en) | Anti-first-pass effect compounds | |
| DE3940094C2 (https=) | ||
| EP1368048B1 (de) | Cannabis extrakten pharmazeutische zusammensetzung | |
| EP2344154B1 (en) | Compositions that include anthocyanidins and methods of use | |
| EP2222320B1 (de) | Neuer mariendistelextrakt, verfahren zur herstellung und verwendung | |
| DE69230958T2 (de) | Arzneizusammensetzung auf Basis von Dioxabicyclo[3.3.0]octanderivaten | |
| US5962044A (en) | Citrus extract | |
| DE4106026A1 (de) | Pharmazeutische zubereitungen enthaltend eine gallussaeureverbindung und/oder quercetin sowie verfahren zur isolierung dieser verbindungen | |
| US6124477A (en) | Anti-first-pass effect compounds | |
| US20030235632A1 (en) | Anti-first-pass effect compounds | |
| US5990154A (en) | Anti-first-pass effect compounds and citrus extract | |
| DE69814118T2 (de) | Anti-first-pass-effect-substanzen | |
| DE4028945A1 (de) | Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung | |
| DE60216118T2 (de) | Sesquiterpenoid-derivate mit adipozytendifferenzierungshemmender wirkung | |
| EP0950411B1 (de) | Verfahren zur Herstellung eines Extraktes aus Copalchirinde und Verwendung der Neoflavonoide zur Behandlung von Diabetes | |
| WO1998024316A1 (en) | Anti-first-pass effect compounds and citrus extract | |
| MXPA00001714A (en) | Anti-first-pass effect compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |